definiens: or, collectively, as the RECITALSWHEREAS, AVEO and KHK ( as defined herein ) have previously entered into the KHKAgreement ( as defined herein ) under which they have collaborated in the development, manufacture and commercialization of products incorporating the proprietary compound knownas tivozanib for the treatment of cancer, with AVEO holding the rights to develop andcommercialize such products outside of Asia;WHEREAS, Partner is engaged in the development and commercialization of specialtypharmaceutical products in Europe and other countries around the world ; andWHEREAS, Partner is interested in obtaining an exclusive right and license to developand commercialize tivozanib in the Field ( as defined herein ) in the countries listed in Exhibit A(the ), and AVEO is willing to grant such rights and licenses to Partner, whileretaining all rights outside of the Field and the Partner Territory, all as more particularly set forthbelow